BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9605421)

  • 21. Regulation of lung surfactant secretion by phospholipase A2.
    Liu L
    J Cell Biochem; 1999 Jan; 72(1):103-10. PubMed ID: 10025671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets.
    Börsch-Haubold AG; Kramer RM; Watson SP
    Eur J Biochem; 1997 May; 245(3):751-9. PubMed ID: 9183015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytosolic phospholipase A2 activation is essential for beta 1 and beta 2 integrin-dependent adhesion of human eosinophils.
    Zhu X; Muñoz NM; Kim KP; Sano H; Cho W; Leff AR
    J Immunol; 1999 Sep; 163(6):3423-9. PubMed ID: 10477614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of different protein kinases and phospholipases A2 in phorbol ester (TPA)-induced arachidonic acid liberation in bovine platelets.
    Lehr M; Griessbach K
    Mediators Inflamm; 2000; 9(1):31-4. PubMed ID: 10877452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
    Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
    Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity.
    Gil B; Sanz MJ; Terencio MC; Gunasegaran R; Payá M; Alcaraz MJ
    Biochem Pharmacol; 1997 Mar; 53(5):733-40. PubMed ID: 9113093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the cytosolic phospholipase A2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187.
    Xue D; Xu J; McGuire SO; Devitre D; Sun GY
    Neurochem Res; 1999 Oct; 24(10):1285-91. PubMed ID: 10492524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
    Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
    Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity.
    Springer DM; Luh BY; Bronson JJ; McElhone KE; Mansuri MM; Gregor KR; Nettleton DO; Stanley PL; Tramposch KM
    Bioorg Med Chem; 2000 May; 8(5):1087-109. PubMed ID: 10882020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
    Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
    Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of two biochemically distinct phospholipase A2 activities in human platelet, monocyte, and neutrophil.
    Marshall LA; Roshak A
    Biochem Cell Biol; 1993; 71(7-8):331-9. PubMed ID: 8123250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus.
    Sala A; Recio MC; Giner RM; Máñez S; Ríos JL
    Life Sci; 2000; 66(2):PL35-40. PubMed ID: 10666016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of several forms of phospholipase A2 in mouse epidermal keratinocytes.
    Li-Stiles B; Lo HH; Fischer SM
    J Lipid Res; 1998 Mar; 39(3):569-82. PubMed ID: 9548589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of calcium-dependent phospholipase A2 activity in membrane preparation of rabbit neutrophils. Absence of activation by fMet-Leu-Phe, phorbol 12-myristate 13-acetate and A-kinase.
    Matsumoto T; Tao W; Sha'afi RI
    Biochem J; 1988 Mar; 250(2):343-8. PubMed ID: 3128281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceramide enhances susceptibility of membrane phospholipids to phospholipase A2 through modification of lipid organization in platelet membranes.
    Hashizume T; Kitatani K; Kageura T; Hayama M; Akiba S; Sato T
    Biol Pharm Bull; 1999 Dec; 22(12):1275-8. PubMed ID: 10746154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
    Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
    Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of a cytosolic phospholipase A2 from bovine adrenal medulla.
    Petit K; De Block J; De Potter W
    J Neurochem; 1995 Jan; 64(1):139-46. PubMed ID: 7798907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of Ca(2+)-dependent phospholipases A2 from rat kidney.
    Aarsman AJ; Schalkwijk CG; Neys FW; Iijima N; Wherrett JR; van den Bosch H
    Arch Biochem Biophys; 1996 Jul; 331(1):95-103. PubMed ID: 8660688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human recombinant platelet phospholipase A2 exacerbates poly-L-arginine induced rat paw edema.
    Cirino G; Cicala C; Sorrentino L
    Inflammation; 1994 Feb; 18(1):59-66. PubMed ID: 8206646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2.
    Kang MS; Jung SY; Jung KM; Kim SK; Ahn KH; Kim DK
    Mol Cells; 2008 Nov; 26(5):481-5. PubMed ID: 18688177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.